Transhuman Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 1

Professionals

  • Investments
  • 20

  • Portfolio
  • 12

  • Exits
  • 4

Exits

Transhuman Capital General Information

Company Description

Founded in 2014, Transhuman Capital is a venture capital firm based in Ann Arbor, Michigan. The firm seeks to invest in the therapeutics, biotechnology, medical devices, and healthcare technologies sectors.

Business Details

Year Founded
2014
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • Ann Arbor, MI
  • United States

Transhuman Capital Investments (20)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Retension Pharmaceutical 21-Aug-2024 Early Stage VC Biotechnology Clinical Trials - Phase 2
Response Pharmaceuticals 28-Jun-2024 Drug Discovery Clinical Trials - Phase 2
Kriya Therapeutics 26-Jul-2023 Drug Discovery Generating Revenue
Bond Biosciences 25-Jan-2022 Drug Discovery Clinical Trials - General
EVOQ Therapeutics 25-Oct-2021 Biotechnology Startup
Eight Sleep 30-Aug-2021 Electronics (B2C) Generating Revenue
Asalyxa Bio 26-Jul-2021 Drug Delivery Out of Business
Kriya Therapeutics 14-Jul-2021 Drug Discovery Generating Revenue
Dvant Pharmaceuticals 19-Mar-2021 Seed Round Drug Discovery Stealth
Silicon Therapeutics 26-Feb-2021 Buyout/LBO Drug Discovery Clinical Trials - Phase 1
You’re viewing 10 of 20 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Transhuman Capital Exits (4)

Company Name Exit Date Exit Type Exit Size
Asalyxa Bio 05-Jul-2024 Out of Business
Roivant Sciences 30-Sep-2021
Sio Gene Therapies 11-Jun-2015 IPO
Marinus Pharmaceuticals 31-Jul-2014 IPO
To view Transhuman Capital’s complete exits history, request access »

Transhuman Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Transhuman Capital FAQs

  • What is Transhuman Capital?

    Founded in 2014, Transhuman Capital is a venture capital firm based in Ann Arbor, Michigan.

  • When was Transhuman Capital founded?

    Transhuman Capital was founded in 2014.

  • Where is Transhuman Capital headquartered?

    Transhuman Capital is headquartered in Ann Arbor, MI.

  • How many investments has Transhuman Capital made?

    Transhuman Capital has made 20 investments.

  • What has Transhuman Capital invested in?

    Transhuman Capital has made numerous investments in companies like Retension Pharmaceutical, Response Pharmaceuticals, and Kriya Therapeutics within the Biotechnology and Drug Discovery industries.

  • What has Transhuman Capital invested in recently?

    Transhuman Capital's latest investment was on 21-Aug-2024 in Retension Pharmaceutical, a company within the Biotechnology industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »